The National Taiwan University Hospital (NTUH) introduced yesterday a new therapy that can effectively reduce recurrences of bladder cancer while limiting harmful side effects.
"Over the past four years, we have treated 50 patients with the new approach," said Pu Yeong-shiau (
The normal recurrence rate of bladder cancer stands at around 50 percent within two years of removal.
In the new treatment, named MDP intravesical combination chemotherapy, three anticancer agents are introduced into the bladder after the removal of the tumor, Pu said.
Nationally, around 1,500 people contract bladder cancer every year and about 600 people die of the disease annually, according to the Department of Health.
Seventy percent of bladder tumors are superficial, which means the cancer is lying on the surface of the bladder's walls and can be scraped off. In these cases, transurethral bladder tumor resection is used to remove the tumor.
The operation is referred to as "transurethral" because it is performed through the urethra, Pu said.
Patients undergoing the operation can keep their bladders, however, 30 percent of bladder tumors become invasive, meaning the cancer has grown into the walls of the bladder.
In those cases, the bladder needs to be removed, Pu said.
MDP intravesical combination chemotherapy is applied to patients who have undergone transurethral bladder tumor resection and still have their bladders.
The most commonly used method to reduce recurrences is called intravesical BCG [Basillus Calmette-Guerin] therapy, Pu said.
At present, BCG is the most proven and effective agent to reduce recurrences of bladder cancer and can reduce the recurrence rate to 40 percent, Pu said.
However, according to Pu, although BCG therapy is highly effective, it also causes serious side effects.
"Ninety percent of patients taking BCG therapy experience urinary problems such as continued pain and burning, frequency, blood or blood clots in the urine," Pu said.
"Nearly 50 percent of the patients also suffer flu-like symptoms. Some even have serious complications such as tuberculosis and prostate tuberculosis," Pu said.
In MND intravesical combination chemotherapy, three anticancer agents, mitomycin-C, doxorubicin and cisplatin are instilled into patients' bladders after the removal of the tumor.
"We instill 30mm of mitomycin into the bladder 24 hours after removal of the tumor to kill the remaining cancer cells. The patient discharges the agent when he or she urinates," Pu said.
"One week later, we instill 30mm of doxorubicin. Another week later we instill 30mm of cisplatin," Pu said.
Eight cycles of the treatment are required to complete the therapy, which takes three years in all.
"If a recurrence does not take place during the three years, it is very unlikely the cancer will return" Pu said.
"The cost of MND intravesical combination chemotherapy is much lower than BCG therapy," Pu added.
Pu also gave tips to prevent bladder cancer.
"Don't smoke. Don't dye your hair or use too much cosmetics or nail polish -- those are cancer-triggering substances. Don't eat too much fried food or pickled vegetables," Pu said.
Travel agencies in Taiwan are working to secure alternative flights for travelers bound for New Zealand for the Lunar New Year holiday, as Air New Zealand workers are set to strike next week. The airline said that it has confirmed that the planned industrial action by its international wide-body cabin crew would go ahead on Thursday and Friday next week. While the Auckland-based carrier pledged to take reasonable measures to mitigate the impact of the workers’ strike, an Air New Zealand flight arriving at Taipei from Auckland on Thursday and another flight departing from Taipei for Auckland on Saturday would have to
The Taipei City Government yesterday confirmed that it has negotiated a royalties of NT$12.2 billion (US$380 million) with artificial intelligence (AI) chip giant Nvidia Corp, with the earliest possible signing date set for Wednesday next week. The city has been preparing for Nvidia to build its Taiwan headquarters in Beitou-Shilin Technology Park since last year, and the project has now entered its final stage before the contract is signed. Taipei Mayor Chiang Wan-an (蔣萬安) said the city government has completed the royalty price negotiations and would now push through the remaining procedures to sign the contract before
Taipei Zoo welcomes the Lunar New Year this year through its efforts to protect an endangered species of horse native to central Asia that was once fully extinct outside of captivity. The festival ushering in the Year of the Horse would draw attention to the zoo’s four specimens of Przewalski’s horse, named for a Russian geographer who first encountered them in the late 19th century across the steppes of western Mongolia. “Visitors will look at the horses and think that since this is the Year of the Horse: ‘I want to get to know horses,’” said zookeeper Chen Yun-chieh, who has been
The Ministry of Foreign Affairs on Thursday said the name of the Taiwanese Representative Office in Lithuania was agreed by both sides, after Lithuania’s prime minister described a 2021 decision to let Taiwan set up a de facto embassy in Vilnius as a “mistake.” Lithuanian Prime Minister Inga Ruginiene, who entered office in September last year, told the Baltic News Service on Tuesday that Lithuania had begun taking “small first steps” aimed at restoring ties with Beijing. The ministry in a statement said that Taiwan and Lithuania are important partners that share the values of freedom and democracy. Since the establishment of the